drugset / Trial / NCT02475265
Transdermal Estrogen in Older Premenopausal Women With Anorexia Nervosa
Phase 2
Completed
11 enrolled
Massachusetts General Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
NaSingle-groupOpen-labelTreatment
Summary
Decreased bone strength is a common and serious medical problem present in many women with anorexia nervosa. Women with decreased bone strength are more likely to suffer broken bones than women with normal bone strength. This study will investigate whether the use of transdermal estrogen can improve bone mineral density (BMD) and bone microarchitecture in women with anorexia nervosa anorexia nervosa when used for 6 months.
Timeline
- Start
- 2015-07
- Primary completion
- 2018-06-27
- Completion
- 2018-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Estradiol | Other / unclassified | 0.045 mg | Other |
| Background | Levonorgestrel | Small molecule | 0.015 mg | Other |